AnalystBook Research · Company Intelligence

DAILY JOURNAL CORP

DJCONasdaq

Built from DAILY JOURNAL CORP's own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

Net income increased 43.6% to $112.1M, while Operating cash flow increased 15080.9% to $13.3M.

The read at a glance✓ Audited against SEC data
  • ScaleFY2025 revenue N/AOK
  • ProfitabilityNet income $112.1MOK
  • Cash generationFree cash flow $13.3MOK
  • AccountingNo applicable forensic screenNote
  • Insiders0 buys; 0 sells in 365 daysNote
  • CapitalComparable payout data unavailableNote

Business

DAILY JOURNAL CORP: AI will likely also create new and better ways for customers to achieve their mandates, of which the Company is positioning to play a valuable role.

Where the revenue comes from

Fiscal 2025, as DAILY JOURNAL CORP reports it. History and quarterly detail are in the app.

  • Journal Technologies$69.9M
  • Traditional Business$17.8M

Leadership changes

From DAILY JOURNAL CORP's own filings, the day they're filed.

  • Community Foundations · director · appointment
  • Consolidated Unit Certificates · departure

Latest filings

  • 8-K · Company announcement2026-08-12
  • 10-Q · Quarterly report2026-08-12
  • DEF 14A · Annual proxy (pay & governance)2026-07-30
  • 10-Q · Quarterly report2026-05-14
  • 8-K · Company announcement2026-05-14
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about DAILY JOURNAL CORP, every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.